Loading companies…
AL
Axo Longevity
United Kingdom · Healthtech
Axo Longevity is a preventive-health membership that combines recurring laboratory testing with personalised insights and an AI health coach.
Product and customers
Members complete blood and urine testing through accredited partner laboratories. Axo turns more than 100 biomarkers into an explained health dashboard, tracks results over time and provides an individual action plan and ongoing AI-supported guidance.
The service is operating through a network of partner laboratories and offers recurring six-month testing cycles in several European markets.
- Headquarters
- London
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5M | 51 Ventures — ParticipantCistern Capital — ParticipantDaniel Kulle — ParticipantDr. Jorge Planas — ParticipantEverywhere Ventures — ParticipantIzou Partners — ParticipantLifeX Ventures — ParticipantMS&AD Ventures — ParticipantNIAN Sports & Entertainment — ParticipantUNQ — Participant |
Investors
51 VenturesJoined SeedCistern CapitalJoined SeedDaniel KulleJoined SeedDr. Jorge PlanasJoined SeedEverywhere VenturesJoined SeedIzou PartnersJoined SeedLifeX VenturesJoined SeedMS&AD VenturesJoined SeedNIAN Sports & EntertainmentJoined SeedUNQJoined SeedCoverage
Sep 16, 2026Axo Longevity · SeedSimilar companies
GMGeneral MedicineAn online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.$120M · Series B
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
Blue Health IntelligenceBlue Health Intelligence combines a one-hour health assessment with doctor-led interpretation and a digital plan for preventive care.€3.4M · €3.4 million growth capital